Ablation of Rnf213 retards progression of diabetes in the Akita mouse

Biochemical and Biophysical Research Communications

Volumn 432, Issue 3, 2013, Pages 519-525

  Kobayashi, Hatasu ^a   Yamazaki, Satoru ^b   Takashima, Seiji ^c   Liu, Wanyang ^a   Okuda, Hiroko ^a   Yan, Junxia ^a   Fujii, Yukiko ^a   Hitomi, Toshiaki ^a   Harada, Kouji H ^a   Habu, Toshiyuki ^a   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Akita mouse; Diabetes; Knockout mouse; Moyamoya disease; Rnf213

Indexed keywords

GLUCOSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INSULIN; LEPTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CELL ASSAY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FOOD INTAKE; GENE; GENE INACTIVATION; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RNF213 GENE; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN-SECRETING CELLS; LEPTIN; MICE; MICE, KNOCKOUT; MOYAMOYA DISEASE; TRANSCRIPTION FACTOR CHOP; UBIQUITIN-PROTEIN LIGASES;

MUS;

EID: 84874975450     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.015     Document Type: Article

References (22)

1. Suzuki J., Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 1969, 20:288-299.
2. Scott R.M., Smith E.R. Moyamoya disease and moyamoya syndrome. N. Engl. J. Med. 2009, 360:1226-1237.
3. Kainth D.S., Chaudhry S.A., Kainth H.S., Suri F.K., Qureshi A.I. Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease. Neurosurgery 2013, 72:210-215.
4. Okazaki K., Kakita A., Tanaka H., Kimura K., Minagawa M., Morita T., Takahashi H. Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1. Neuropathology 2010, 30:627-633.
5. Bober M.B., Khan N., Kaplan J., Lewis K., Feinstein J.A., Scott C.I., Steinberg G.K. Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am. J. Med. Genet. A 2010, 152A:960-965.
6. Anwar A.J., Walker J.D., Frier B.M. Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet. Med. 1998, 15:160-163.
7. Kamoun M., Charfi N., Rekik N., Mnif M.F., Mnif F., Kmiha H., Mnif Z., Abid M. Neurofibromatosis and Type 1 diabetes mellitus: an unusual association. Diabet. Med. 2009, 26:1180-1181.
8. Bower R.S., Mallory G.W., Nwojo M., Meyer F.B., Kudva Y.C. Diabetes mellitus and the moyamoya syndrome. Ann. Intern. Med. 2012, 157:387-388.
9. Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T., Hashikata H., Matsuura N., Yamazaki S., Toyoda A., Kikuta K., Takagi Y., Harada K.H., Fujiyama A., Herzig R., Krischek B., Zou L., Kim J.E., Kitakaze M., Miyamoto S., Nagata K., Hashimoto N., Koizumi A. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011, 6:e22542.
10. Deshaies R.J., Joazeiro C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78:399-434.
11. White S.R., Lauring B. AAA + ATPases: achieving diversity of function with conserved machinery. Traffic 2007, 8:1657-1667.
12. Yoshioka M., Kayo T., Ikeda T., Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997, 46:887-894.
13. Wang J., Takeuchi T., Tanaka S., Kubo S.K., Kayo T., Lu D., Takata K., Koizumi A., Izumi T. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J. Clin. Invest. 1999, 103:27-37.
14. +/Akita pancreatic beta cells. Genes Cells 2004, 9:261-270.
15. Miyazaki J., Araki K., Yamato E., Ikegami H., Asano T., Shibasaki Y., Oka Y., Yamamura K. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 1990, 127:126-132.
16. Toyoshima M., Asakawa A., Fujimiya M., Inoue K., Inoue S., Kinboshi M., Koizumi A. Dimorphic gene expression patterns of anorexigenic and orexigenic peptides in hypothalamus account male and female hyperphagia in Akita type 1 diabetic mice. Biochem. Biophys. Res. Commun. 2007, 352:703-708.
17. Martin-Gronert M.S., Ozanne S.E. Metabolic programming of insulin action and secretion. Diabetes Obes. Metab. 2012, 14(Suppl. 3):29-39.
18. Marciniak S.J., Yun C.Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H.P., Ron D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004, 18:3066-3077.
19. Yamane S., Hamamoto Y., Harashima S., Harada N., Hamasaki A., Toyoda K., Fujita K., Joo E., Seino Y., Inagaki N. GLP-1 receptor agonist attenuates endoplasmic reticulum stress-mediated β-cell damage in Akita mice. J. Diabetes Invest. 2011, 2:104-110.
20. Jurczyk A., Pino S.C., O'Sullivan-Murphy B., Addorio M., Lidstone E.A., Diiorio P., Lipson K.L., Standley C., Fogarty K., Lifshitz L., Urano F., Mordes J.P., Greiner D.L., Rossini A.A., Bortell R. A novel role for the centrosomal protein, pericentrin, in regulation of insulin secretory vesicle docking in mouse pancreatic beta-cells. PLoS One 2010, 5:e11812.
21. Allen J.R., Nguyen L.X., Sargent K.E., Lipson K.L., Hackett A., Urano F. High ER stress in beta-cells stimulates intracellular degradation of misfolded insulin. Biochem. Biophys. Res. Commun. 2004, 324:166-170.
22. Liu M., Hodish I., Rhodes C.J., Arvan P. Proinsulin maturation, misfolding, and proteotoxicity. Proc. Natl. Acad. Sci. USA 2007, 104:15841-15846.